LCA Lung Clinical Forum. 21 st October 2014
|
|
- Juliana Parrish
- 5 years ago
- Views:
Transcription
1 LCA Lung Clinical Forum 21 st October 2014
2 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group
3 Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA
4 Commissioning Intentions for Lung Cancer 2015/16 S U E M A U G H N, C L I N I C A L A D V I S O R, T R A N S F O R M I N G C A N C E R S E R V I C E S T E A M F O R L O N D O N
5 Commissioning Intentions In high level terms, how the commissioner intends to commission services from Providers during 2015/16. In line with the NHS Standard Contract, providers are given six months notification for any potential changes to services. Overarching principles Compliance with NICE Introduction of timed pathways Follow up in line with NCSI
6 16 pan-london cancer commissioning intentions- 4 highly relevant to lung To support the delivery of the Pan London Cancer Strategy and to reduce variation across providers: 1. All GPs to have direct access to same day chest x-ray for high risk of cancer and access for low risk, not no risk of cancer a) In order to support the reduction of the risk of delayed diagnosis, all commissioned services will be required to formally report A&E, Urgent Care Centres and inpatient chest x-rays (CxR) 2. All commissioned cancer services will participate in the National Cancer Peer Review Programme (NCPR) or other quality assurance programme as defined by commissioners 3. All cancer services commissioned will be required to demonstrate robust treatment decision making through MDT 4. All lung cancer services will be commissioned in line with best practice through a timed pathway a) Endobronchial US (EBUS) services are commissioned to an agreed service specification and tariff
7 Pathway elements In addition pathways to include: 1. Abnormal CxR straight to CT 2. Abnormal CxR flagged to MDT plus GP (? Use of consultant upgrade) 3. CT prior to first OPA
8 Lung Quality requirements Need to be reported to commissioners quarterly - Quality /Information items aligned with the requirements of LUCADA or peer review where possible In addition an annual audit of 30 cases against the key elements For example: - 95% CT prior to Bronchoscopy - 80% CNS present at diagnosis - A thoracic surgeon is present at all MDTs All cancer MDTs to be quorate with core membership present at 95% of meetings and that individual core members attend 66% of meetings
9 Lung Quality requirements Questions
10 Priorities for the next 6 months, implementation and support required Dr Liz Sawicka Chair - LCA Lung Pathway Group
11 Priorities for next 6 months Succession Planning Commissioning Intentions Implementation and compliance against 62 day timed pathway CT before 1 st appointment Review of clinical guidelines Mesothelioma guidelines and set up of subgroup Lung survivorship work programme Lung Palliative Care work programme Palliative Lead required End of life care prompt tool GP education programme Pathology and Radiology standards
12 Pathology Standards - recap Quality Standard 1 Patients with lung cancer should have their diagnosis confirmed histologically unless patient is unwilling or investigation is too dangerous. Quality Standard 1 Measure: The proportion of all lung cancer patients who have a histological diagnosis Notes: This measure should reflect the functioning of the MDT as a whole
13 Pathology Standards - recap Quality Standard 2 Patients with histologically confirmed non-small cell lung cancer should be assigned an accurate histological sub-type, according to WHO and IASLC recommendations Quality Standard 2 Measures: The proportion of non-small cell carcinoma patients assigned a diagnosis of non-small cell carcinoma NOS The relative proportions of non-small cell NOS, squamous cell carcinoma, adenocarcinoma and other subtypes Notes: Reflects quality of samples taken by clinicians and experience of pathologists
14 Pathology Standards - recap Quality Standard 3 Patients with histologically confirmed non-small cell non-squamous lung cancer who are treated with palliative systemic therapy should be tested for EGFR prior to treatment commencing It is recommended that ALK testing should also be undertaken in this group Quality Standard 3 Measures: The proportion of patients with histologically confirmed non-small cell non-squamous lung cancer who are treated with palliative systemic therapy who have an EGFR test result available prior to first-line treatment. The proportion of patients with histologically confirmed non-small cell non-squamous lung cancer who are treated with palliative systemic therapy who have an ALK test result available prior to second-line treatment. The proportion of EGFR and ALK tests requested that are deemed inadequate or fail analysis Notes Reflects effectiveness of testing policy, sample quality and whether pathologists are preserving tissue Any accredited testing methodology may be used
15 Pathology Standards - recap Quality Standard 4 Pathologists reporting lung cancer samples should participate in the specialist lung cancer EQA scheme. Quality Standard 4 Measure: The proportion of pathologists reporting lung cancer specimens who participate in the lung EQA scheme
16 Questions
17 Lung Compliance Metrics What can I do to ensure compliance For more information on compliance metrics please contact stephenscott@nhs.net Stephen Scott Senior Cancer Information Analyst, LCA
18 What can I do to ensure compliance 1. Validate data to ensure accurate picture 2. Correct data flow issues 3. If data accurate consider any improvements in service
19 Questions
20 Optimal diagnostic pathways for lung cancer to deliver 62 day pathway
21 Radiology Standards Achieving 62 day pathway Role of CT and Radiology Dr Anand Devaraj Consultant Radiologist, St George s Healthcare NHS Trust
22 Background 62 day wait target across LCA Access to Diagnostics Audit Feb 2014
23 Patient with mass on CXR GP TWR referral to chest clinic Pt seen in clinic CT requested CT performed and reported Pt seen in clinic (Provisional diagnosis and next tests).
24
25 Proposed Pathway 62 Day Timed Pathway for Lung LCA Feedback Day 0 Moderate large pleural effusion Urgent 2ww referral with CXR Internal referrals A&E referrals Incidental findings Routine GP referral 1 st OPA* Referrals triaged, Screened, U&Es checked. CT ordered and booked prior to 1 st OPA No CT required /requested Max Day 14 Bloods Aspiration 1 st OPA clinic with CT result, Spirometry, Bloods CT suggests Cancer - Is Patient Likely to need radical treatment? Fit for radical treatment? Likely to want radical treatment? 1 st OPA clinic, spirometry, bloods, CT No cancer Discharge to GP or move to alternative pathway CT Yes No *Order concurrently PET scan * Bronchoscopy Image guided biopsy, EBUS * Assessment of fitness * Diagnostics- Bronchoscopy, Image guided biopsy, pleural biopsy MDM Discussion of treatment options No cancer Discharge to GP Day Day OPA Cancer Confirmed and treatment plan agreed with patient discussed (CNS present) Metastatic disease from alternative primary refer to appropriate MDT Suitable for radical treatment urgeon Suitable for palliative treatment or intervention Day Refer surgeon Refer Oncologist Palliative intervention/ symptom control Specialist palliative care Palliative care Day 62 [Type text] Surgery Chemotherapy Radiotherapy
26 Proposed Pathway 62 Day Timed Pathway for Lung LCA Feedback Day 0 Moderate large pleural effusion Urgent 2ww referral with CXR Internal referrals A&E referrals Incidental findings Routine GP referral 1 st OPA* Referrals triaged, Screened, U&Es checked. CT ordered and booked prior to 1 st OPA No CT required /requested Max Day 14 Bloods Aspiration 1 st OPA clinic with CT result, Spirometry, Bloods CT suggests Cancer - Is Patient Likely to need radical treatment? Fit for radical treatment? Likely to want radical treatment? 1 st OPA clinic, spirometry, bloods, CT No cancer Discharge to GP or move to alternative pathway CT Yes No PET scan * Diagnostics- Bronchoscopy, Image
27 Scoping Exercise Questionnaire sent to all LCA MDTs Can you offer TWR referrals a CT before the clinic appointment? What are the obstacles?
28 Feedback Most TWR referrals are not lung cancer Requests not always immediately available to clinicians Requests need appropriate vetting Patients need to be contacted (who and how? /appropriate over telephone?) What matters is time to CT (not whether it is before of after clinic appointment).
29 Radiology Standards Timing of CT scan For appropriate referrals the CT scan should be performed before the outpatient appointment Ideally requires new 2ww proforma with EGFR measurements requested by GP Referrals need to be triaged and CT request made This may have resource implications such as nursing support to achieve this Access to PET Scanning Standard should be no more than 2 weeks Time to tissue Standard should be to have the biopsy result available for the MDT within 2 weeks of biopsy referral date regardless of method of sampling
30 Questions
31 Discussion Questions Is the implementation of CT prior to first appointment reasonable? What are the main problems? Would it help to implement the lung 2WW proforma? Process Agree 2ww proforma content and then work collaboratively with GP led group to understand their challenges for implementation and roll out Will this be enough to make earlier diagnosis of lung cancer? What else can we do or influence?
32 Summary and Close Dr Liz Sawicka Chair - LCA Lung Pathway Group
33 Thank you for coming today Presentations will be available on the website after a week
National Optimal Lung Cancer Pathway
National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationThere are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.
December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT
More informationNICE Quality Standards and COF
NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationStreamlining the lung diagnostic pathway (A87)
Streamlining the lung diagnostic pathway (A87) Crawley CCG with Surrey and Sussex Healthcare NHS Trust Evaluation January 2017 Summary A new Straight-to-CT pathway for patients with an abnormal CXR result
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician NECN NORTH TEES AND HARTLEPOOL North Tees And Hartlepool Lung MDT (11-2C-1) - 2011/12 Dr D N Leitch Compliance Self
More information6 th LCA Lung Clinical Forum. 24 th June 2014
6 th LCA Lung Clinical Forum 24 th June 2014 Welcome Dr Liz Sawicka, Chair - LCA Lung Pathway Group LCA Pathology Standards Developed in line with national clinical guidelines and quality standards issued
More informationFaster Cancer Treatment Indicators: Use cases
Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationImproving diagnostic pathways for patients with suspected lung cancer
Improving diagnostic pathways for patients with suspected lung cancer Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England,
More informationAmbulatory lung biopsy: a new model for the NHS. Dr Sam Hare Barnet Hospital Royal Free London NHS Trust
Ambulatory lung biopsy: a new model for the NHS Dr Sam Hare Barnet Hospital Royal Free London NHS Trust Lung cancer Leading cause of UK cancer mortality UK: 2 nd lowest European survival rate 62-day RTT
More informationImproving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
More informationCancer Services Position & Recovery Plan June 2015
Appendix 6 Cancer Services Position & Recovery Plan June 2015 Introduction The Trust is required to achieve 85% compliance for patients on a 62 day pathway from the referral date to the date they receive
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document
More informationSupra Network Sarcoma Advisory Group (SAG) Annual Report
London and South East Sarcoma Network Supra Network Sarcoma Advisory Group (SAG) Annual Report 2011-2012 Hosted by Date: December 2012 Version: 2 Review Date: September 2013 London Cancer Integrated Cancer
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationOne Stop Prostate Biopsy Protocol Author Consultation Date Approved
One Stop Prostate Biopsy Protocol Author Consultation Date Approved Urology Nurse Practioner PROTOCOL FOR MEN ATTENDING A ONE STOP PROSTATE BIOPSY CLINIC RATIONALE Prostate cancer is the most common cancer
More informationLung Pathway Group Metrics. Stephen Scott Senior Cancer Information Analyst
Lung Pathway Group Metrics Stephen Scott Senior Cancer Information Analyst 2 Metrics Collated for Lung pathway group Cancer Waiting Times Data Sourced from Open Exeter % of cases staged Sourced from TCR
More informationClinical Advice to Cancer Alliances for the Commissioning of the whole Lung Cancer Pathway
Clinical Advice to Cancer Alliances for the Commissioning of the whole Lung Cancer Pathway This document was produced by the Lung Cancer Clinical Expert August 2017 Document Title: Clinical Advice to Cancer
More informationRichard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead
GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,
More informationHow can we facilitate cross-boundary working in Greater Manchester?
How can we facilitate cross-boundary working in Greater Manchester? Emma Halkyard Nurse Clinician Cross boundary working: where are we now? Our patients are complex Our pathways are complex Our treatments
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationQuality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester
Quality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester Greater Manchester Cancer Clinical Director: Mr Mohammed Absar Pathway Manager: Rebecca Price Pathway approval: 24
More informationActivity Report March 2012 February 2013
Lung Cancer Managed Clinical Network Activity Report March 2012 February 2013 John McPhelim Lead Lung Cancer Nurse MCN Clinical Lead Kevin Campbell Network Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationCancer of Unknown Primary (CUP)
Cancer of Unknown Primary (CUP) Pathways and Guidelines V1.0 London Cancer September 2013 The following pathways and guidelines document has been compiled by the London Cancer CUP technical subgroup and
More informationAcute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director
Acute Oncology 2014 Martin Eatock Consultant Medical Oncologist NICaN Medical Director Patients admitted with cancer have a longer than average stay Berger et al. Clin Medicine (2013) Questions If your
More informationLung cancer timed clinical pathways
Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against
More informationMANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION
CLINICAL POLICY MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION DOCUMENT REF: PCLASCORD (Version No. 1.4) Name and designation of policy author(s) Approved by (committee, group, manager)
More informationChallenges for the Lung Cancer Pathway Group
Challenges for the Lung Cancer Pathway Group Liz Sawicka Chair Lung Pathway Group Thoracic Physician and Lung Cancer Lead Princess Royal University Hospital SLHT 2 The Problem - Varied outcome for patients
More informationA06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)
A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MVCN EAST AND NORTH HERTFORDSHIRE Mount Vernon Cancer Centre Cancer Network MDT (11-2K-1) - 2011/12 Date Self Assessment Completed
More informationLCA Lung Cancer Clinical Guidelines. December 2013 (updated March 2016)
LCA Lung Cancer Clinical Guidelines December 2013 (updated March 2016) LCA LUNG CANCER CLINICAL GUIDELINES Contents Introduction... 5 1 Prevention... 7 1.1 Background information... 7 1.2 Smoking cessation
More informationShared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1
Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Gynaecological sarcomas Version 1 Background This guidance is to provide direction for the management of patients with sarcomas
More informationImproving Outcomes for People with Sarcoma
NHS National Institute for Health and Clinical Excellence Guidance on Cancer Services Improving Outcomes for People with Sarcoma List of All Recommendations March 2006 Developed for NICE by the National
More informationManchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases
Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Date: April 2015 Date for review: April 2018 1. Principles The recognised specialist HPB MDT for Greater
More informationGROUP 1: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases. Including: Excluding:
GROUP 1: Including: Excluding: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases Solid pulmonary nodules 8mm diameter / 300mm3 volume and BROCK risk of malignancy
More informationDelivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol
Delivering 62 Day GP Cancer Waits in a Complex Landscape Hannah Marder Cancer Manager University Hospitals Bristol Overview The 62 day GP target Cancer pathways What causes breaches? Good practice and
More informationSouth West Regional Cancer Program. Cancer Plan
South West Regional Cancer Program Cancer Plan 2016-2019 1. Cancer System Planning Cancer Care Ontario s role as the government s cancer advisor includes the development and implementation of a provincial
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationRuth Howkins Deputy National Coordinator National Cancer Peer Review
Ruth Howkins Deputy National Coordinator National Cancer Peer Review Purpose of Peer Review To ensure services are as safe as possible To improve the quality and effectiveness of care To improve the patient
More informationWork Programme/Service Delivery Plan 2010/2013
Essex and East Suffolk Gynaecological Cancer Network Site Specific Group Work Programme/Service Delivery Plan 2010/2013 Version Number 1.2 Author Members of the NSSG Date Written June 2010 Reviewed May
More informationUnknown Primary Service for patients at Chesterfield Royal Hospital
Unknown Primary Service for patients at Chesterfield Royal Hospital David Brooks Macmillan Consultant in Palliative Medicine Louise Merriman GP Cancer Lead With thanks to Macmillan Cancer Support, who
More informationSTANDARDS FOR UPPER GI CANCERS 2004
STANDARDS FOR UPPER GI CANCERS 2004 Source: CSCG Title: UPPER GI CANCERS STANDARDS Version: 10/CONSULTATION Page 1 of 33 1. INTRODUCTION TO THE CANCER STANDARDS 1.1 These Cancer Standards replace the previous
More informationGuideline for the Follow-up of Patients with Gynaecological Malignancies
Guideline for the Follow-up of Patients with Gynaecological Malignancies Version History Version Date Summary of Change/Process 2.0 20.02.08 Endorsed by the Governance Committee 2.1 18.11.10 Circulated
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary
More informationLifting the Goalposts for Standards of Care in Lung Cancer
Lifting the Goalposts for Standards of Care in Lung Cancer LCA Lung Clinical Forum 25 th March 2014 Welcome and LCA Lung Pathway Update Dr Liz Sawicka, Chair - LCA Lung Pathway Group Lung Forum Informatics
More informationLung Cancer Case Study
Lung Cancer Case Study Presented by s GP Education Programme 2 Part One Initial presentation 60 year old lady, presents with a 6 week history of right sided chest pain. The pain is like a dull ache, but
More informationDelivering stratified follow-up in primary care for Prostate Cancer Patients - The NCL Approach. Dr Elizabeth Babatunde Macmillan GP
Delivering stratified follow-up in primary care for Prostate Cancer Patients - The NCL Approach Dr Elizabeth Babatunde Macmillan GP Background 2 Objectives Enhance patient experience and outcomes by providing
More informationAppendix 4 Urology Care Pathways
Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable
More informationProgress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England
Report by the Comptroller and Auditor General Department of Health, NHS England and Public Health England Progress in improving cancer services and outcomes in England HC 949 SESSION 2014-15 15 JANUARY
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: December 2018 Version: 8.0 Wales Cancer Owner: Network and Welsh Government Status Draft 1 P a g e Purpose of Document This document
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation (Trust) Team DCN POOLE Poole THYROID ONLY MDT (11-2I-2) - 2011/12 Peer Review Visit Date 18th August 2011 Compliance THYROID ONLY
More informationRe-audit of Radiotherapy Waiting Times 2005
Abstract Re-audit of Radiotherapy Waiting Times 2005 E. Summers, M Williams Royal College of Radiologists, 38 Portland Place, London W1B 4JQ, UK Aim: To determine current waiting times for radiotherapy
More informationNational Standards for Sarcoma Services
National Standards for Sarcoma Services 2009 TABLE OF CONTENTS 1. INTRODUCTION TO THE NATIONAL CANCER STANDARDS...2 2. METHODOLOGY...4 3. FORMAT...4 4. INTRODUCTION TO SARCOMA...5 STANDARDS TOPIC: ORGANISATION...10
More informationNational Standards for Sarcoma Services 2009
National Standards for Sarcoma Services 2009 Crown copyright July 2010 F1101011 Contents 1. Introduction to the National Cancer Standards 2. Methodology 3. Format 4. Introduction to Sarcoma Standards Topic:
More informationB14/S/b 2013/14 NHS STANDARD CONTRACT FOR PENILE CANCER SECTION B PART 1 - SERVICE SPECIFICATIONS. Service Specification No.
B14/S/b 2013/14 NHS STANDARD CONTRACT FOR PENILE CANCER SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No. Service Commissioner Lead Provider Lead Period Date of Review B14/S/b Penile
More informationA. Service Specification
A. Service Specification Service Specification No: 1767 Service Adult Highly Specialist Pain Management Services Commissioner Lead For local completion Lead For local completion 1. Scope 1.1 Prescribed
More informationSt. Joseph s Regional Thoracic Program. Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton
St. Joseph s Regional Thoracic Program Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton SJHH REGIONAL THORACIC PROGRAM Collaboration & Integration Thoracic Surgery - Malignant
More informationSCAN Lung Group Friday 16 th November pm
SCAN Lung Group Friday 16 th November 2012 14.15 16.15pm Oncology Seminar Room, Western General Hospital, Edinburgh with videolink to Dumfries MINUTES Present Diana Borthwick Martin Keith Kate Macdonald
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Sarcoma Specialist Multi Disciplinary Team for Suspected Sarcoma of Soft Tissue Extremities (limbs and trunk
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Cancer of Unknown Primary Network Site Specific Group Revision due: April 2019 Page 1 of 11 VERSION CONTROL THIS IS A CONTROLLED DOCUMENT.
More informationNational Cancer Update. Stephen Parsons Director
National Cancer Update Stephen Parsons Director Cancer Update: An Overview The new NHS landscape Progress on cancer The new landscape The Health and Social Care Act New Ministerial Team Jeremy Hunt Earl
More informationCancer of Unknown Primary Service
Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationStaging Issues: Lung Cancer & Mesothelioma. Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG
Staging Issues: Lung Cancer & Mesothelioma Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG Staging systems Non-Small Cell Lung Cancer (>85%): UICC TNM v6 used until 1.1.10 transition since then to v7
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationLCA Mental Health & Psychological Support Mapping
LCA Mental Health & Psychological Support Mapping November 2013 Contents 1 Introduction... 3 2 Method... 3 3 Results... 3 3.1 Information Centres... 3 3.2 Training and Education... 5 3.3 Level Two Supervision...
More informationActivity Report April 2012 March 2013
Colorectal Cancer Managed Clinical Network Activity Report April 2012 March 2013 Paul Horgan Professor of Surgery MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks Sarcoma National Managed Clinical Network Activity Report April 2013 March 2014 Dr Jeff White Consultant Oncologist NMCN Clinical Lead Lindsay Campbell
More informationEarly Inflammatory Arthritis Pathway Rheumatology Service Commissioner Lead
Schedule 2 Part A Service Specification Number 04/MSKT/0014 Care Pathway/Service Early Inflammatory Arthritis Pathway Rheumatology Service Commissioner Lead CCP for Musculoskeletal & Trauma Provider Lead
More informationSouth West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
More informationHow to make changes in the NHS
How to make changes in the NHS Keith Willett Prof of Orthopaedic Trauma Surgery University of Oxford prev. National Clinical Director for Trauma Care ATOCP Conference Oxford 2016 Medical Director for Acute
More informationDRAFT SARCOMA MEASURES
Gateway 15612 Draft Sarcoma Measures Page 1 of 44 DH INFORMATION READER BOX Policy Estates HR / Workforce Commissioning Management IM & T Policy Planning / Finance Clinical Social Care / Partnership Working
More informationSurvivorship Guidelines. September 2013 (updated August 2015)
Survivorship Guidelines September 2013 (updated August 2015) CONTENTS Contents 1 Introduction... 3 2 Background... 3 3 Recommendations and Rationale... 4 Appendix 1: Holistic Needs Assessment... 9 Appendix
More informationColorectal Cancer Pathway Clinical Subgroup Tuesday 4 th September pm 4 pm CTCCU Seminar Room UHSM
Manchester Cancer Colorectal Cancer Pathway Clinical Subgroup Tuesday 4 th September2014 2 pm 4 pm CTCCU Seminar Room UHSM Attendance Sarah Duff Michael Braun David Bisset Mohammed Sadat Deborah Hitchen
More informationCancer of Unknown Primary (CUP) Protocol
1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date
More informationLara Kujtan, MD; Abdulraheem Qasem, MD
The Treatment of Lung Cancer Between 2013-2014 at Truman Medical Center: A Retrospective Review in Fulfillment of the Requirements of Standard 4.6 (Monitoring Compliance with Evidence- Based Guidelines)
More informationNational Standards for Acute Oncology Services
Cancer National Specialist Advisory Group National Standards for Acute Oncology Services June 2016 TABLE OF CONTENTS 1. PURPOSE... 2 2. INTRODUCTION... 2 3. STRATEGIC CONTEXT... 4 4. SCOPE OF ACUTE ONCOLOGY
More informationResearch Within LCA. Dr Mary O Brien
Research Within LCA Dr Mary O Brien Agenda Align with NCRN trials Scope what is ongoing in LCA Directory of PIs, research nurses, trial coordinators, data managers AIM 1. Increase recruitment to ongoing
More informationPATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE
PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network
More informationEvaluation of Cancer Outcomes Barwon South West Registry
Evaluation of Cancer Outcomes Barwon South West Registry Data Request Form Applicant details Applicant name: Position: Email: Project start date: Date: Telephone: Project completion date: Project details
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009
More informationHealth Board/Region: All-Wales
Peer Review: Cancer Sub-site: Gynaecology Health Board/Region: All-Wales Cycle: Second Date of review: February 2018 This report describes the findings and themes observed by clinical review panels during
More informationUpper GI Cancer Network Site-Specific Group. Work Programme/Service Delivery Plan 2011/14
Upper GI Cancer Network Site-Specific Group Work Programme/Service Delivery Plan 2011/14 1 UPPER GI NSSG Work Programme/Service Delivery Plan AGREEMENT COVER SHEET 2011/14 This Work Programme has been
More informationImproving diagnostic pathways for patients with vague symptoms
Improving diagnostic pathways for patients with vague symptoms Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer
More informationImproving Cancer Pathways. Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust
Improving Cancer Pathways Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust Background Poor / inconsistent 62 day performance, across a number of specialities
More informationClinical Advice for the Commissioning of the Whole Bowel Cancer Pathway
Clinical Advice for the Commissioning of the Whole Bowel Cancer Pathway This document was produced by the Colorectal Cancer Clinical Expert Group November 2017 Clinical Advice to Cancer Alliances for the
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. Service Commissioner Lead Provider Lead Period Date of Review B10/S/a DRAFT - Thoracic Surgery 12 months 1. Population Needs
More informationAsthma Audit Development Project: Hospital pilot information
Asthma Audit Development Project: Hospital pilot information Contents Summary... 1 Pilot process summary 1 Introduction and background... 2 What it will cover 2 Timescales 2 Hospital pilot... 3 Why should
More informationStandard Operating Procedure: Early Intervention in Psychosis Access Times
Corporate Standard Operating Procedure: Early Intervention in Psychosis Access Times Document Control Summary Status: New Version: V1.0 Date: Author/Owner: Rob Abell, Senior Performance Development Manager
More informationCancer and Data in the New NHS May Di Riley, Director Clinical Outcomes
Cancer and Data in the New NHS May 2011 Di Riley, Director Clinical Outcomes Overarching NHS context Financial constraints White Paper GP Commissioning/Commissioning Board Public Health England National
More informationBladder Cancer Guidelines
Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder
More informationLondon Cancer Alliance
1 Purpose of the document... 3 2 Background... 3 3 Case for change... 3 4 The King s and Guy s and St Thomas prostate pathway... 4 4.1 Characteristics of the pathway... 4 4.2 Key factors to ensuring implementation...
More information